Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies

BACKGROUND: In this post hoc analysis, we assessed patient characteristics as predictors of dronedarone trough concentrations and characterized the relationship of trough concentrations of dronedarone with its efficacy and safety. HYPOTHESIS: Dronedarone is recommended as a 400 mg twice daily dose t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thind, Munveer, McKindley, David S., Reiffel, James A., Naccarelli, Gerald V., Stewart, John, Kowey, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799059/
https://www.ncbi.nlm.nih.gov/pubmed/35032136
http://dx.doi.org/10.1002/clc.23768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799059/
https://www.ncbi.nlm.nih.gov/pubmed/35032136
http://dx.doi.org/10.1002/clc.23768

Ejemplares similares